Genetic Effects: Accounting for diet and age
The human genome is made up of 3 billion base pairs, but variations in just 1% of them cause differences in traits observed between individuals, from blood cell counts to body weight and behaviour (Walters et al., 2019). This 1% is extremely important to geneticists for several reasons (Timpson et al., 2018). First, they want to understand how much genetics contributes to differences between individuals. Second, knowing more about this 1% of the genome could help doctors predict whether a person is likely to develop certain diseases. Finally, identifying the genetic variants that affect a specific trait can be the first step towards unravelling its underlying biological mechanism. For traits related to disease, this can then result in the development of therapeutic interventions.
Determining how genetic variants lead to a specific phenotype is a real challenge. Most common traits and diseases – including type 2 diabetes and major depression – are affected by thousands of genetic variants across the genome, each with a tiny effect on the trait studied (Timpson et al., 2018). Now, in eLife, Anil Raj (Calico Life Sciences), Gary Churchill (Jackson Laboratory) and colleagues – including Kevin Wright as first author – report that the effect of a genetic variant on the body weight of mice can be diet- and age-dependent, further complicating the relationship between genes and traits (Wright et al., 2022).
Body weight is a quantitative trait that can easily be measured in hundreds of mice, making it easier to detect subtle changes. It also lends itself to studying age-related effects, since mice can be weighed each week of their lives without the procedure affecting the animal. To investigate these effects, Wright et al. weighed 960 female mice once per week between the ages of 60 and 660 days old. The mice were given unlimited food (ad libitum feeding) until they were 180 days old, and were then randomly assigned to one of five dietary groups: ad libitum feeding, 20% caloric restriction, 40% caloric restriction, fast one day per week, or fast two days per week.
Each mouse was also genotyped to ascertain the two letters of its DNA at each genomic position known to vary in this mouse population. With these data in hand, Wright et al. proceeded to dissect the genetic architecture of body weight in mice, yielding one of the finest studies in the field. Using software developed specifically to capture context-dependent genetic effects, such as age and diet (Dahl et al., 2020), Wright et al. found that before dietary intervention at 180 days of age, genetics made a substantial contribution to variation in body weight, accounting for 60% to 80% of the weight variance observed in the mice. After dietary intervention, however, diet became the most important factor explaining variation in body weight. In the group with a 40% caloric restriction, genetics kept explaining about 80% of the weight variance, but in the other dietary groups, genetic effects decreased over time.
Wright et al. next sought to identify individual genetic loci influencing body weight and to investigate the relationship between genetic effects and diet. To do so, they leveraged the fact that the mice they studied are all descended from eight known founders many generations ago (Svenson et al., 2012) and that these founders differed from each other at 34.5 million base-pairs across the genome. In the mouse population studied by Wright et al., each chromosome is a fine-grained mosaic of the eight founder genomes and, at each locus, the eight ancestral haplotypes (small chromosome chunks inherited from the founders) can be recognised using appropriate software (Broman et al., 2019). To identify loci influencing body weight, the mice can be divided based on the haplotype they have at the locus and, if there are differences in body weight between the haplotype groups, this is evidence for ‘diet-independent’ effects. The mice can also be divided based on both their dietary group and their ancestral haplotype; in this case, variations between the haplotype groups that differ in magnitude between the dietary groups point to ‘diet-dependent’ effects (Figure 1).
Wright et al. identified five loci with only diet-independent effects and ten with only diet-dependent effects. This finding demonstrates that failing to model diet-dependent effects will result in missing genetic loci important to determining body weight. Additionally, Wright et al. also identified nine loci with both diet-independent and diet-dependent effects, raising the question of whether the same haplotype groupings give rise to the two types of effects. They found that different haplotype groupings give rise to diet-independent and diet-dependent effects in all cases. This supports the notion that different genetic effects drive diet-independent differences in body weight across the entire population and diet-dependent differences within dietary groups. In terms of the specific DNA code, this means that these loci harbour multiple base-pair variants and that different variants or different combinations of letters at the same variants give rise to diet-independent and diet-dependent effects.
In addition to identifying diet-dependent effects, Wright et al. also demonstrate that genetic variants can have different effects at different ages, and that this trend can be non-linear. For example, the effect of a specific genetic variant could increase, peak at a certain age, and then decrease. A future study on the same mice will examine the interplay between genetics and diet in the context of longevity.
Wright et al.’s findings highlight the need for taking context into account in genetic studies. This need has been recognised for some time, but it is difficult to meet due to uncertainty about what the relevant context might be for any given trait (Ashbrook et al., 2021; McAllister et al., 2017). Moreover, the statistical models needed to account for context are getting more and more complex, requiring ever larger sample sizes. With their results, Wright et al. make significant headway in this field.
References
-
A robust method uncovers significant context-specific heritability in diverse complex traitsAmerican Journal of Human Genetics 106:71–91.https://doi.org/10.1016/j.ajhg.2019.11.015
-
Current challenges and new opportunities for gene-environment interaction studies of complex diseasesAmerican Journal of Epidemiology 186:753–761.https://doi.org/10.1093/aje/kwx227
-
Genetic architecture: the shape of the genetic contribution to human traits and diseaseNature Reviews. Genetics 19:110–124.https://doi.org/10.1038/nrg.2017.101
Article and author information
Author details
Publication history
Copyright
© 2022, Tonnelé and Baud
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 769
- views
-
- 136
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Genetics and Genomics
- Immunology and Inflammation
PIK3R1 encodes three regulatory subunits of class IA phosphoinositide 3-kinase (PI3K), each associating with any of three catalytic subunits, namely p110α, p110β, or p110δ. Constitutional PIK3R1 mutations cause diseases with a genotype-phenotype relationship not yet fully explained: heterozygous loss-of-function mutations cause SHORT syndrome, featuring insulin resistance and short stature attributed to reduced p110α function, while heterozygous activating mutations cause immunodeficiency, attributed to p110δ activation and known as APDS2. Surprisingly, APDS2 patients do not show features of p110α hyperactivation, but do commonly have SHORT syndrome-like features, suggesting p110α hypofunction. We sought to investigate this. In dermal fibroblasts from an APDS2 patient, we found no increased PI3K signalling, with p110δ expression markedly reduced. In preadipocytes, the APDS2 variant was potently dominant negative, associating with Irs1 and Irs2 but failing to heterodimerise with p110α. This attenuation of p110α signalling by a p110δ-activating PIK3R1 variant potentially explains co-incidence of gain-of-function and loss-of-function PIK3R1 phenotypes.
-
- Developmental Biology
- Genetics and Genomics
The establishment and growth of the arterial endothelium requires the coordinated expression of numerous genes. However, regulation of this process is not yet fully understood. Here, we combined in silico analysis with transgenic mice and zebrafish models to characterize arterial-specific enhancers associated with eight key arterial identity genes (Acvrl1/Alk1, Cxcr4, Cxcl12, Efnb2, Gja4/Cx37, Gja5/Cx40, Nrp1 and Unc5b). Next, to elucidate the regulatory pathways upstream of arterial gene transcription, we investigated the transcription factors binding each arterial enhancer compared to a similar assessment of non-arterial endothelial enhancers. These results found that binding of SOXF and ETS factors was a common occurrence at both arterial and pan-endothelial enhancers, suggesting neither are sufficient to direct arterial specificity. Conversely, FOX motifs independent of ETS motifs were over-represented at arterial enhancers. Further, MEF2 and RBPJ binding was enriched but not ubiquitous at arterial enhancers, potentially linked to specific patterns of behaviour within the arterial endothelium. Lastly, there was no shared or arterial-specific signature for WNT-associated TCF/LEF, TGFβ/BMP-associated SMAD1/5 and SMAD2/3, shear stress-associated KLF4 or venous-enriched NR2F2. This cohort of well characterized and in vivo-verified enhancers can now provide a platform for future studies into the interaction of different transcriptional and signalling pathways with arterial gene expression.